231 related articles for article (PubMed ID: 25481381)
1. Cross-talk between alpha1D-adrenoceptors and transient receptor potential vanilloid type 1 triggers prostate cancer cell proliferation.
Morelli MB; Amantini C; Nabissi M; Liberati S; Cardinali C; Farfariello V; Tomassoni D; Quaglia W; Piergentili A; Bonifazi A; Del Bello F; Santoni M; Mammana G; Servi L; Filosa A; Gismondi A; Santoni G
BMC Cancer; 2014 Dec; 14():921. PubMed ID: 25481381
[TBL] [Abstract][Full Text] [Related]
2. Expression of the transient receptor potential vanilloid 1 (TRPV1) in LNCaP and PC-3 prostate cancer cells and in human prostate tissue.
Sanchez MG; Sanchez AM; Collado B; Malagarie-Cazenave S; Olea N; Carmena MJ; Prieto JC; Diaz-Laviada I I
Eur J Pharmacol; 2005 May; 515(1-3):20-7. PubMed ID: 15913603
[TBL] [Abstract][Full Text] [Related]
3. Growth hormone (GH) receptors in prostate cancer: gene expression in human tissues and cell lines and characterization, GH signaling and androgen receptor regulation in LNCaP cells.
Weiss-Messer E; Merom O; Adi A; Karry R; Bidosee M; Ber R; Kaploun A; Stein A; Barkey RJ
Mol Cell Endocrinol; 2004 May; 220(1-2):109-23. PubMed ID: 15196705
[TBL] [Abstract][Full Text] [Related]
4. Prostate growth inhibition by subtype-selective alpha(1)-adrenoceptor antagonist naftopidil in benign prostatic hyperplasia.
Kojima Y; Sasaki S; Oda N; Koshimizu TA; Hayashi Y; Kiniwa M; Tsujimoto G; Kohri K
Prostate; 2009 Oct; 69(14):1521-8. PubMed ID: 19544328
[TBL] [Abstract][Full Text] [Related]
5. Androgen receptor as a regulator of ZEB2 expression and its implications in epithelial-to-mesenchymal transition in prostate cancer.
Jacob S; Nayak S; Fernandes G; Barai RS; Menon S; Chaudhari UK; Kholkute SD; Sachdeva G
Endocr Relat Cancer; 2014 Jun; 21(3):473-86. PubMed ID: 24812058
[TBL] [Abstract][Full Text] [Related]
6. Expression profiles and functional associations of endogenous androgen receptor and caveolin-1 in prostate cancer cell lines.
Bennett NC; Hooper JD; Johnson DW; Gobe GC
Prostate; 2014 May; 74(5):478-87. PubMed ID: 24375805
[TBL] [Abstract][Full Text] [Related]
7. A selective alpha1D-adrenoreceptor antagonist inhibits human prostate cancer cell proliferation and motility "in vitro".
Colciago A; Mornati O; Ferri N; Castelnovo LF; Fumagalli L; Bolchi C; Pallavicini M; Valoti E; Negri-Cesi P
Pharmacol Res; 2016 Jan; 103():215-26. PubMed ID: 26621245
[TBL] [Abstract][Full Text] [Related]
8. Prostate androgen-regulated gene: a novel potential target for androgen-independent prostate cancer therapy.
Xu XF; Zhou SW; Zhang X; Ye ZQ; Zhang JH; Ma X; Zheng T; Li HZ
Asian J Androl; 2006 Jul; 8(4):455-62. PubMed ID: 16763722
[TBL] [Abstract][Full Text] [Related]
9. Thermo-sensitive transient receptor potential vanilloid channel-1 regulates intracellular calcium and triggers chromogranin A secretion in pancreatic neuroendocrine BON-1 tumor cells.
Mergler S; Skrzypski M; Sassek M; Pietrzak P; Pucci C; Wiedenmann B; Strowski MZ
Cell Signal; 2012 Jan; 24(1):233-46. PubMed ID: 21945155
[TBL] [Abstract][Full Text] [Related]
10. Receptor-operated Ca2+ entry mediated by TRPC3/TRPC6 proteins in rat prostate smooth muscle (PS1) cell line.
Thebault S; Zholos A; Enfissi A; Slomianny C; Dewailly E; Roudbaraki M; Parys J; Prevarskaya N
J Cell Physiol; 2005 Jul; 204(1):320-8. PubMed ID: 15672411
[TBL] [Abstract][Full Text] [Related]
11. PC3, but not DU145, human prostate cancer cells retain the coregulators required for tumor suppressor ability of androgen receptor.
Litvinov IV; Antony L; Dalrymple SL; Becker R; Cheng L; Isaacs JT
Prostate; 2006 Sep; 66(12):1329-38. PubMed ID: 16835890
[TBL] [Abstract][Full Text] [Related]
12. The prostate cancer-up-regulated long noncoding RNA PlncRNA-1 modulates apoptosis and proliferation through reciprocal regulation of androgen receptor.
Cui Z; Ren S; Lu J; Wang F; Xu W; Sun Y; Wei M; Chen J; Gao X; Xu C; Mao JH; Sun Y
Urol Oncol; 2013 Oct; 31(7):1117-23. PubMed ID: 22264502
[TBL] [Abstract][Full Text] [Related]
13. Activation of endogenous TRPV1 fails to induce overstimulation-based cytotoxicity in breast and prostate cancer cells but not in pain-sensing neurons.
Pecze L; Jósvay K; Blum W; Petrovics G; Vizler C; Oláh Z; Schwaller B
Biochim Biophys Acta; 2016 Aug; 1863(8):2054-64. PubMed ID: 27180305
[TBL] [Abstract][Full Text] [Related]
14. Increased expressions of cannabinoid receptor-1 and transient receptor potential vanilloid-1 in human prostate carcinoma.
Czifra G; Varga A; Nyeste K; Marincsák R; Tóth BI; Kovács I; Kovács L; Bíró T
J Cancer Res Clin Oncol; 2009 Apr; 135(4):507-14. PubMed ID: 18830626
[TBL] [Abstract][Full Text] [Related]
15. TRPV6 channel controls prostate cancer cell proliferation via Ca(2+)/NFAT-dependent pathways.
Lehen'kyi V; Flourakis M; Skryma R; Prevarskaya N
Oncogene; 2007 Nov; 26(52):7380-5. PubMed ID: 17533368
[TBL] [Abstract][Full Text] [Related]
16. Heterodimerization with beta2-adrenergic receptors promotes surface expression and functional activity of alpha1D-adrenergic receptors.
Uberti MA; Hague C; Oller H; Minneman KP; Hall RA
J Pharmacol Exp Ther; 2005 Apr; 313(1):16-23. PubMed ID: 15615865
[TBL] [Abstract][Full Text] [Related]
17. Prolactin- and testosterone-induced carboxypeptidase-D correlates with increased nitrotyrosines and Ki67 in prostate cancer.
Thomas LN; Merrimen J; Bell DG; Rendon R; Too CK
Prostate; 2015 Nov; 75(15):1726-36. PubMed ID: 26202060
[TBL] [Abstract][Full Text] [Related]
18. Extended survivability of prostate cancer cells in the absence of trophic factors: increased proliferation, evasion of apoptosis, and the role of apoptosis proteins.
Tang DG; Li L; Chopra DP; Porter AT
Cancer Res; 1998 Aug; 58(15):3466-79. PubMed ID: 9699682
[TBL] [Abstract][Full Text] [Related]
19. Change of expression levels of alpha1-adrenoceptor subtypes by administration of alpha1d-adrenoceptor-subtype-selective antagonist naftopidil in benign prostate hyperplasia patients.
Kojima Y; Sasaki S; Shinoura H; Hayase M; Kubota Y; Hayashi Y; Tsujimoto G; Kohri K
Prostate; 2007 Sep; 67(12):1285-92. PubMed ID: 17626248
[TBL] [Abstract][Full Text] [Related]
20. Capsaicin-induced apoptosis of glioma cells is mediated by TRPV1 vanilloid receptor and requires p38 MAPK activation.
Amantini C; Mosca M; Nabissi M; Lucciarini R; Caprodossi S; Arcella A; Giangaspero F; Santoni G
J Neurochem; 2007 Aug; 102(3):977-90. PubMed ID: 17442041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
